Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83:313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023))

Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, Kristan van der Vos, Daniel J. Vis, Linde Braaf, Annegien Broeks, Antonio Alcaraz, Lodewyk F.A. Wessels, More Authors

Pattern Recognition and Bioinformatics

Research output: Contribution to journal › Comment/Letter to the editor › Scientific › peer-review

12 Downloads (Pure)

1 Article

1 results

2023
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
Gil-Jimenez, A., van Dorp, J., Contreras-Sanz, A., van der Vos, K., Vis, D. J., Braaf, L., Broeks, A., Kerkhoven, R., van Kessel, K. E. M., Wessels, L. F. A. & More Authors, 2023, In: European Urology. 83, 4, p. 313-317 5 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
14 Citations (Scopus)

17 Downloads (Pure)

Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83:313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023))

Research output

Search results

Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer